Gary Ingenito - Nov 20, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Med. & Reg. Officer
Signature
/s/ Gary Ingenito
Stock symbol
CPRX
Transactions as of
Nov 20, 2024
Transactions value $
-$653,182
Form type
4
Date filed
11/22/2024, 05:00 PM
Previous filing
Aug 13, 2024
Next filing
Nov 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $152K +38K +73.94% $4.01 89.4K Nov 20, 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$806K -38K -42.51% $21.20 51.4K Nov 20, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -38K -4% $0.00 913K Nov 20, 2024 Common Stock 38K $4.01 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $21.18 to $21.27 per share.
F3 Options vested in three annual tranches beginning on January 2, 2019.